Ranjani Raghavan
Healthcare
B Capital, Chiratae, Peak XV-backed D2C startup Mojocare's books under scanner, fires 80% staff
A year after investing $20 million in Series A funding, investors B Capital, Chiratae Ventures, Better Capital, and Peak XV ......
TMT
Pharmeasy approaches Avendus to tap on external funds
E-pharmacy major PharmEasy has appointed investment bank Avendus Capital to tap external capital, even as its existing investors are planning ......
Finance
Peak XV to double down on cross-border bets: Shailendra Singh after Sequoia spinoff
On Tuesday, storied venture capital firm Sequoia Capital spun out its India and South East Asia entity into a separate ......
Healthcare
PAG seeks to pick up minority stake in injectables firm
Asian investment firm PAG plans to acquire a significant minority stake in specialty injectables company RK Pharma Inc. and its ......
TMT
Blackstone, French company weigh bids for IT firm
French digital business services provider Teleperformance SE and private equity firm Blackstone Group Inc. are planning separate bids for Everise ......
TMT
Carlyle may buy into Quest Global as two other PE firms look to exit
Private equity giant Carlyle Group is on the verge of acquiring a substantial stake, exceeding 20%, in the engineering services ......
Consumer
Warburg Pincus set to seal control deal for bathroom fittings firm
Private equity firm Warburg Pincus is set to acquire a majority stake in Watertec (India) Pvt. Ltd, a bathroom accessories ......
Finance
Bain Capital emerges as front-runner for Porus Labs
Bain Capital has emerged as the front-runner for Porus Laboratories having signed an exclusivity pact with promoters of the Hyderabad-based ......
Finance
3One4 Capital hits fourth VC fund's final close at $200 mn
3one4 Capital, an early-stage venture capital investor, raised $200 million for its fourth fund to invest in technology-driven startups. The ......
Finance
Zydus promoters eye $200 mn from sale of private clinical research biz
Zydus Group is exploring the sale of its clinical research business, Cliantha Research Ltd, in a deal that could potentially ......
